New company, Velsera, represents Summa Equity's vision to improve global health outcomes
Boston, San Francisco, Stockholm, 12 January 2023 - New company Velsera was announced today at the...
Read about Pierian and our partners in the news.
Boston, San Francisco, Stockholm, 12 January 2023 - New company Velsera was announced today at the...
We are excited to announce our new partnership with Genome Medical, the leading telehealth provider...
ST. LOUIS, June 15, 2022 --Pierian®, a global leader in advanced clinical genomics technology and...
Partnership enables comprehensive clinical information to deliver optimal patient care
Funds to drive commercial expansion as growing number of facilities bring genomics into communities...
Partnership enables local oncology genomic testing to broaden patient access to expedited,...
Comprehensive Genetic Profiling Supplements Germline and Companion Diagnostic Results to Provide...
Additional Illumina assays to be combined with the Pierian platform to reduce time, cost, and...
Multiple targeted assays from Pillar Biosciences to be combined with the Pierian platform to reduce...
Collaboration will create integrated clinical interpretation and reporting solution
Intermountain Healthcare joins Pierian’s partner network to accelerate precision medicine
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst...
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform...
As posted on BusinessWire
PierianDx, the leading clinical genomics technology company that enables precision medicine,...
PierianDx, the leading genomics technology company that enables precision medicine programs and...
Pierian announced today that Cleveland Clinic will utilize its integrated “one space” workflow and...
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced...
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting,...
Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs...
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements...
ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and...
ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading bioinformatics platform for...
ST LOUIS, MO/GAINSVILLE, GA – Pierian, the forerunner in clinical genomic informatics, and Aeon...
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that...
ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that the University of Virginia...
ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that the Inova Translational Medicine...
ST. LOUIS MO – PierianDx announced today that Moffitt Cancer Center in Tampa, FL and Fletcher Allen...
© 2024 PierianDx